Are Stuwitz Berg1, Christopher Stephen Inchley, Audun Aase, Hans Olav Fjaerli, Reidun Bull, Ingeborg Aaberge, Truls Michael Leegaard, Britt Nakstad. 1. From the *Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway; †Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway; ‡Department of Radiology and §Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway; and ¶Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND: Improved Childhood Immunizations Programs, especially the introduction of pneumococcal vaccination, better diagnostic methods and the importance of reduced antibiotic misuse, make this a critical time to increase knowledge on the etiology of pediatric pneumonia. Our main objective was to identify the contribution of various microbiological species that causes pneumonia in previously healthy children and adolescents in a population with high pneumococcal conjugate vaccine coverage. METHODS: This prospective, observational study enrolled patients with clinical and radiological signs of pneumonia over a 2-year period. Both inpatients and outpatients were included. Paired sera, nasopharyngeal polymerase chain reaction and bacterial cultures from blood and pleura were analyzed to detect potential viral and bacterial causative pathogens. RESULTS: TWO HUNDRED AND SIXTY-FIVE: cases of clinical and radiological verified pneumonia were identified. The pneumococcal vaccine coverage was 85%. We identified a causative pathogen in 84.2% of all cases; 63.4% with single viral etiology, 11.3% with pneumococcus and 7.5% with mycoplasma infection. Respiratory syncytial virus was the most common pathogen in children younger than 5 years, whereas mycoplasma was the most common in older children. CONCLUSIONS: We identified the majority of 265 cases with radiology proven pneumonia as single viral infections, predominantly respiratory syncytial virus and a much lower proportion of bacterial causes. These findings may impact pneumonia management guidelines in areas where widespread pneumococcal vaccination is provided and contribute to reduced antibiotic overuse in pediatric pneumonia.
BACKGROUND: Improved Childhood Immunizations Programs, especially the introduction of pneumococcal vaccination, better diagnostic methods and the importance of reduced antibiotic misuse, make this a critical time to increase knowledge on the etiology of pediatric pneumonia. Our main objective was to identify the contribution of various microbiological species that causes pneumonia in previously healthy children and adolescents in a population with high pneumococcal conjugate vaccine coverage. METHODS: This prospective, observational study enrolled patients with clinical and radiological signs of pneumonia over a 2-year period. Both inpatients and outpatients were included. Paired sera, nasopharyngeal polymerase chain reaction and bacterial cultures from blood and pleura were analyzed to detect potential viral and bacterial causative pathogens. RESULTS: TWO HUNDRED AND SIXTY-FIVE: cases of clinical and radiological verified pneumonia were identified. The pneumococcal vaccine coverage was 85%. We identified a causative pathogen in 84.2% of all cases; 63.4% with single viral etiology, 11.3% with pneumococcus and 7.5% with mycoplasma infection. Respiratory syncytial virus was the most common pathogen in children younger than 5 years, whereas mycoplasma was the most common in older children. CONCLUSIONS: We identified the majority of 265 cases with radiology proven pneumonia as single viral infections, predominantly respiratory syncytial virus and a much lower proportion of bacterial causes. These findings may impact pneumonia management guidelines in areas where widespread pneumococcal vaccination is provided and contribute to reduced antibiotic overuse in pediatric pneumonia.
Authors: Are Stuwitz Berg; Christopher Stephen Inchley; Hans Olav Fjaerli; Truls Michael Leegaard; Morten Lindbaek; Britt Nakstad Journal: Eur J Pediatr Date: 2017-03-09 Impact factor: 3.183
Authors: Mejbah U Bhuiyan; Christopher C Blyth; Rachel West; Jurissa Lang; Tasmina Rahman; Caitlyn Granland; Camilla de Gier; Meredith L Borland; Ruth B Thornton; Lea-Ann S Kirkham; Andrew Martin; Peter C Richmond; David W Smith; Adam Jaffe; Thomas L Snelling Journal: BMC Pulm Med Date: 2019-04-02 Impact factor: 3.317
Authors: Christian Magnus Thaulow; Hege Salvesen Blix; Beate Horsberg Eriksen; Ingvild Ask; Tor Åge Myklebust; Dag Berild Journal: BMJ Open Date: 2019-05-27 Impact factor: 2.692
Authors: August Wrotek; Julita Robakiewicz; Katarzyna Pawlik; Patryk Rudzinski; Izabela Pilarska; Aleksandra Jaroń; Aleksandra Imiełowska; Małgorzata Jarzębowska; Katarzyna Zabłocka; Teresa Jackowska Journal: J Clin Med Date: 2022-09-20 Impact factor: 4.964
Authors: Mia Johanna Søndergaard; Martin Barfred Friis; Dennis Schrøder Hansen; Inger Merete Jørgensen Journal: PLoS One Date: 2018-04-26 Impact factor: 3.240
Authors: N Takeuchi; S Naito; M Ohkusu; K Abe; K Shizuno; Y Takahashi; Y Omata; T Nakazawa; K Takeshita; H Hishiki; T Hoshino; Y Sato; N Ishiwada Journal: Epidemiol Infect Date: 2020-04-17 Impact factor: 2.451
Authors: Mejbah Uddin Bhuiyan; Thomas L Snelling; Rachel West; Jurissa Lang; Tasmina Rahman; Caitlyn Granland; Camilla de Gier; Meredith L Borland; Ruth B Thornton; Lea-Ann S Kirkham; Chisha Sikazwe; Andrew C Martin; Peter C Richmond; David W Smith; Adam Jaffe; Christopher C Blyth Journal: Thorax Date: 2018-10-18 Impact factor: 9.139